Insider · CIK 0001493280

Wong Roderick

CIK 0001493280 Name as filed on the most recent filing

Filed as Wong Roderick (61)

104 transaction lines · from 61 filings · filed 2019-04-18 to 2026-04-29 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

25 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2020-04-01 P, Open-market purchase DermTech, Inc.DMTK 276,316, acquired Open Form 4 filing 0001493152-20-005632
2020-03-31 P, Open-market purchase DermTech, Inc.DMTK 56,321, acquired Open Form 4 filing 0001493152-20-005632
2020-03-19 P, Open-market purchase Milestone Pharmaceuticals Inc.MIST 63,804, acquired Open Form 4 filing 0001493152-20-004365
2020-03-18 P, Open-market purchase Milestone Pharmaceuticals Inc.MIST 28,029, acquired Open Form 4 filing 0001493152-20-004365
2020-03-05 P, Open-market purchase DermTech, Inc.DMTK 350,088, acquired Open Form 4 filing 0001493152-20-003458
2020-03-04 P, Open-market purchase DermTech, Inc.DMTK 65,593, acquired Open Form 4 filing 0001493152-20-003458
2020-03-03 P, Open-market purchase DermTech, Inc.DMTK 188,713, acquired Open Form 4 filing 0001493152-20-003458
2020-03-02 P, Open-market purchase DermTech, Inc.DMTK 192,428, acquired Open Form 4 filing 0001493152-20-003252
2020-03-02 P, Open-market purchase Milestone Pharmaceuticals Inc.MIST 1,483,084, acquired Open Form 4 filing 0001493152-20-004347
2020-02-28 P, Open-market purchase DermTech, Inc.DMTK 1,600,788, acquired Open Form 4 filing 0001493152-20-003252
2020-01-13 P, Open-market purchase Milestone Pharmaceuticals Inc.MIST 4,387,500, acquired Open Form 4 filing 0001493152-20-000524
2019-12-31 P, Open-market purchase Milestone Pharmaceuticals Inc.MIST 332,340, acquired Open Form 4 filing 0001493152-20-000046
2019-12-30 P, Open-market purchase Milestone Pharmaceuticals Inc.MIST 20,638, acquired Open Form 4 filing 0001493152-20-000046
2019-12-17 S, Open-market sale Tela Bio, Inc.TELA 407,617, disposed Open Form 4 filing 0001493152-19-019419
2019-12-13 P, Open-market purchase Tela Bio, Inc.TELA 277,121, acquired Open Form 4 filing 0001493152-19-019380
2019-12-11 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 344,024, acquired Open Form 4 filing 0001213900-19-026179
2019-12-10 P, Open-market purchase Rocket Pharmaceuticals, Inc.RCKT 5,006,250, acquired Open Form 4 filing 0001493152-19-019095
2019-12-10 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 269,517, acquired Open Form 4 filing 0001213900-19-025792
2019-12-06 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 510,125, acquired Open Form 4 filing 0001213900-19-025656
2019-12-06 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 4,100,000, acquired Open Form 4 filing 0001213900-19-025587
2019-12-05 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 203,000, acquired Open Form 4 filing 0001213900-19-025446
2019-12-04 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 203,000, acquired Open Form 4 filing 0001213900-19-025338
2019-12-03 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 204,200, acquired Open Form 4 filing 0001213900-19-025233
2019-12-02 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 208,000, acquired Open Form 4 filing 0001213900-19-025233
2019-11-29 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 281,293, acquired Open Form 4 filing 0001213900-19-025233
2019-11-27 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 41,904, acquired Open Form 4 filing 0001213900-19-025026
2019-11-26 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 41,960, acquired Open Form 4 filing 0001213900-19-025026
2019-11-25 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 42,000, acquired Open Form 4 filing 0001213900-19-025026
2019-11-22 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 21,080, acquired Open Form 4 filing 0001213900-19-024510
2019-11-21 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 158,299, acquired Open Form 4 filing 0001213900-19-024510
2019-11-20 P, Open-market purchase Milestone Pharmaceuticals Inc.MIST 6,400,000, acquired Open Form 4 filing 0001493152-19-018241
2019-11-20 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 309,582, acquired Open Form 4 filing 0001213900-19-024510
2019-11-19 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 305,501, acquired Open Form 4 filing 0001213900-19-024124
2019-11-18 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 305,501, acquired Open Form 4 filing 0001213900-19-024124
2019-11-15 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 133,800, acquired Open Form 4 filing 0001213900-19-024124
2019-11-14 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 132,210, acquired Open Form 4 filing 0001213900-19-023579
2019-11-13 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 132,210, acquired Open Form 4 filing 0001213900-19-023579
2019-11-12 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 1,017,000, acquired Open Form 4 filing 0001213900-19-023579
2019-11-11 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 132,340, acquired Open Form 4 filing 0001213900-19-022714
2019-11-08 S, Open-market sale Stoke Therapeutics, Inc.STOK 471,631, disposed Open Form 4 filing 0001493152-19-016926
2019-11-07 P, Open-market purchase Health Sciences Acquisitions CorpHSAC 178,150, acquired Open Form 4 filing 0001213900-19-022714
2019-11-04 P, Open-market purchase Stoke Therapeutics, Inc.STOK 3,066,843, acquired Open Form 4 filing 0001493152-19-016566
2019-11-01 P, Open-market purchase Stoke Therapeutics, Inc.STOK 245,950, acquired Open Form 4 filing 0001493152-19-016346
2019-10-31 P, Open-market purchase Stoke Therapeutics, Inc.STOK 527,659, acquired Open Form 4 filing 0001493152-19-016346
2019-10-30 P, Open-market purchase Stoke Therapeutics, Inc.STOK 1,193,004, acquired Open Form 4 filing 0001493152-19-016346
2019-10-15 P, Open-market purchase Milestone Pharmaceuticals Inc.MIST 19,800, acquired Open Form 4 filing 0001493152-19-015513
2019-10-11 P, Open-market purchase Milestone Pharmaceuticals Inc.MIST 72,791, acquired Open Form 4 filing 0001493152-19-015513
2019-10-10 P, Open-market purchase Milestone Pharmaceuticals Inc.MIST 2,864, acquired Open Form 4 filing 0001493152-19-015513
2019-10-03 P, Open-market purchase Milestone Pharmaceuticals Inc.MIST 34,940, acquired Open Form 4 filing 0001493152-19-014959
2019-10-01 P, Open-market purchase Stoke Therapeutics, Inc.STOK 693,029, acquired Open Form 4 filing 0001493152-19-014877

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 25
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. WONG RODERICK, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001493280

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.